The translocated c-myc oncogene in Burkitt's lymphoma (BL) and murine plasmacytoma (MPC) has been proposed t o be expressed at a stage of differentiation at which the gene is normally silent, resulting in a continuous proliferation and an inhibited terminal differentiation. To determine whether c-myc is differently expressed at the various stages of the differentiation pathway, we used B-type chronic lymphocytic leukemia (8-CLL) cells, representing resting B lymphocytes, inducible t o proliferation and/or differentiation in vitro. The c-myc protein, and lg blight chain and PCA-1 antigen as markers of B-cell maturation, were analyzed in single, morphologically defined cells by immunocytochemical doublestaining. The proliferation of individual cells was determined by 3H-thymidine incorporation and by analysis of Ki-67 anti-OST HEMATOPOIETIC tumors represent clonal
The translocated c-myc oncogene in Burkitt's lymphoma (BL) and murine plasmacytoma (MPC) has been proposed t o be expressed at a stage of differentiation at which the gene is normally silent, resulting in a continuous proliferation and an inhibited terminal differentiation. To determine whether c-myc is differently expressed at the various stages of the differentiation pathway, we used B-type chronic lymphocytic leukemia (8- Chromosomal aberrations probably play a role in deregulation of the genetic programs controlling growth and differentiation. In B-cell tumors, translocations involving the c-myc and Ig loci are common features in Burkitt's lymphoma (BL), murine plasmacytoma (MPC), and rat imm~nocytoma~" but also occur in acute B-lymphoblastic leukemia (BALL).' Similar translocations of c-myc, involving the T-cell receptor loci, have been reported in T-ALL. ' The crucial role of deregulated c-myc expression in malignant transformation of B cells is also suggested by the retroviral integration into the c-myc locus demonstrated in avian' and murine" lymphomas and by the high incidence of B lymphomas in transgenic mice expressing a Ek/c-myc transgene."
Although the precise function of the nuclear myc oncoprotein is unknown, observations made during recent years suggest that it is involved in the control of growth and/or differentiation.'* In vitro differentiation of hematopoietic cell lines, eg, the murine erythroleukemia (MEL)I3 and the human HL-6014 and U-937,15316 is associated with a downregdation of c-myc expression. The significance of this reduction was further suggested by the observations that terminal differentiation is inhibited in MEL" and U-937 cellsI6 constitutively expressing a transferred c-or v-myc gene. In BL and MPC, the normal c-myc allele is transcriptionally silent,18 indicating that the translocated myc oncogene may be expressed at a stage of B-cell differentiation at which c-myc expression normally is nonpermissive. Little is known, however, about c-myc regulation during B-cell differentiation.
Selected B-type chronic lymphocytic leukemia (B-CLL) tumors may be used as model systems for studies of differentiation-associated c-myc expression because B-CLL clones represent resting (Go) B lymphocytes inducible to activation, proliferation, and differentiation closely resembling that of normal B cells.' ' We previously showed that 12-0-tetradecanoyl-phorbol-13-acetate (TPA) induction of B-CLL cells results in a transition of the cells from Go to GI, an increase in RNA and protein synthesis, an orderly expression of B-cell activation and differentiation surface gen expression. The results show that the level of c-myc expression correlates t o the stage of differentiation and t o the proliferative activity. Uninduced resting cells did not express c-myc. The c-myc protein was observed in the highest amount at the proliferative B-lymphoblast stage of maturation and was reduced in plasmablasts and undetectable in plasma cells. The results suggest that maturation of B cells into nonproliferative, terminally differentiated plasma cells is associated with a downregulated c-myc expression and thus support the view that the deregulated c-myc gene in BL and MPC is expressed at an inappropriate stage of maturation and thereby inhibits terminal differentiation. 0 1991 by The American Society of Hematology.
antigens, an increase in the ratio secret0ry:membrane Ig pheavy chain mRNA, a morphologic transition of the cells into lymphoblasts and plasmablasts and secretion of IgM.20~21 The process is accompanied by a dramatic increase in expression of c-myc mRNA and protehw This increase contrasts with the observed downregulation of c-myc during differentiation of MEL, HL-60, and U-937 cells, and suggests that B-cell differentiation is compatible with c-myc expression. Induction of differentiation in B-CLL cells by TPA gives rise to a heterogeneous population of cells representing different stages of maturation, however, and only a few percent of the cells will differentiate terminally into cells with a plasma cell morphology.
To determine whether c-myc expression is preferentially confined to certain stages of B-cell differentiation, we studied the expression of c-myc protein in individual B-CLL cells by immunocytochemical techniques. We used four different protocols for induction of a selected B-CLL clone, B-CLL cells induced by the different protocols is related to the proliferative activity and to the stage of maturation. The c-myc protein is not detectable in resting, unstimulated B-CLL cells, is expressed at a high level at the proliferative lymphoblast stage of differentiation, is reduced at the plasmablast stage, and again is not detectable at the terminal, nonproliferative plasma cell stage of differentiation.
MATERIALS AND METHODS
Cell culture and reagents. Leukemic, monoclonal (IgM) lymphocytes were obtained from a B-CLL patient (183) and isolated by Ficoll-Paque gradient centrifugation. The phenotype of the I83 B-CLL cells has been detailed I83 cells were cultured in RPMI 1640 medium supplemented with 10% newborn calf serum, 2 mmoliL glutamine, 100 IUimL penicillin, 100 pg/mL streptomycin, and 50 pg/mL gentamycin. Heat-inactivated and formalin-ked SAC particles were used at a final concentration of 0.1%. TPA (Sigma, St Louis, MO) was used at a concentration 1.6 x mol/L. BSF-MP6, which is necessary for induction of efficient DNA synthesis and differentiation in I83 B-CLL cells,22~24,25 was obtained in serum-free supernatants from a T-cell hybridoma (MP6)" and used in a concentration of 25% volhol. The major active component in BSF-MP6 was recently identified as thiored o~i n .~' Human recombinant IL-2 (specific activity 7 x 10' Uimg) was purchased from Amgen (Amersham, England) and used at a concentration of 100 UlmL. Human recombinant IL-4 (specific activity IO8 U/mg) was purchased from Genzyme (Boston, MA) and used at a concentration of 100 U/mL. Human recombinant TNF-a (specific activity 6 x lo7 Uimg) was a gift from Dr G. R. Adolf, Ernst-Boehringer Institute, Vienna, Austria, and used at a concentration of 100 ng/mL.
I83 cells, at a density of 2 x IO6 cells/mL, were exposed to TPA, SAC + BSF-MP6 + TNF-a, SAC + BSF-MP6 + IL-2 and TPA + BSF-MP6 + IL-4, respectively, for 6 days. When SAC was included in the stimulation protocol, the cells were exposed to SAC for 2 days, followed by BSF-MP6 + TNF-a or BSF-MP6 + IL-2 as previously described.2'
The morphologic differentiation was studied on May-GriinwaldGiemsa-stained cytospin slide preparations by light microscopy. A minimum of 400 cells were counted. The functional differentiation was determined by measuring the amount of secreted IgM in supernatants using an enzyme-linked immunosorbent assay (ELISA) technique.22 DNA synthesis was determined by incubating cells in triplicate 0.2-mL cultures with 1 pCi of 'H-TdR (specific activity 6.7 Ciimmol, Dupont, Boston, MA) for the last 24 hours of a 6-day incubation period. The cells were harvested on a cell harvester (Skatron, Lierbyen, Norway), and the incorporated radioactivity was determined by a liquid scintillation counter (Beckman, Irvine, CA). For autoradiography, cytocentrifuge slides were fixed in methanoliacetic acid (3:l) or 1% paraformaldehyde (PFA) and overlaid with Kodak (Rochester, NY) nuclear track emulsion, stored for 1 week at 4"C, and then processed with Kodak LX-24 x-ray developer.
For assessment of RNA and DNA content, the cells were stained by A 0 according to DarzunkiewiczZ as detailed previously.2'
The cells were washed phosphate-buffered saline and 2% fetal calf serum labeled on ice for 30 minutes with monoclonal antibodies (MoAbs) PCA-1 (Coulter Immunology, Hialeah, FL). As a second-layer antibody, an FITC-conjugated goat F(ab'), antimouse Ig (Janssen Biochimica, Beerse, Belgium) was used at a final dilution of 1/80. The cells were washed twice and fixed on ice in 1% PFA in PBS. The cells
Acridine orange (AO) staining.
Immunojuorescence and cell sorting.
were subsequently separated into PCA-1' and PCA-1-populations by cell sorting using a FACStar flow cytometer (Beckton Dickinson, Mountain View, CA).
Total cellular RNA was isolated by the LiCVurea procedure?' Denatured total RNA samples (15 kgiwell) were fractionated on a 1% formaldehyde-containing agarose gel, transferred to a nitrocellulose filter, hybridized with a '*P-labeled probe, and washed under stringent conditions as previously described?' A 1.5-kb EcoRIiClaI fragment prepared from a human c-myc clone'" and spanning the third exon of the human c-myc gene was used as a probe. The fragment was "P-labeled by random priming (Multiprime DNA labeling kit, Amersham) to a specific activity > lo8 cpmipg DNA. Autoradiograms were analyzed by densitometric scanning (Shimadzu CS-930, Kyoto, Japan).
The cells were cytocentrifuged, dried for 30 minutes, and then fixed in 1% PFA for 30 minutes. After three washes in PBS, the slides were incubated for 30 minutes with normal goat serum, washed, and subsequently stained or doublestained for 1 hour with specific antibodies. The antibodies used were rabbit anti-human c-myc antiserum" (diluted 1:400), provided by Dr R. Watt of Smith, Kline and French Laboratories (Philadelphia, PA), MoAbs anti-Ki-67'2 (Dakopatts, Kopenhagen, Denmark), diluted 1:lO and anti-human A-chain MoAbs (Becton Dickinson) (diluted 1:40). For blocking experiments, the anti-cmyc antiserum was incubated for 3 hours at room temperature with 1 pg recombinant human c-myc protein" (provided by Dr R Watt) per microliter of antiserum before the cells were labeled. Goat anti-rabbit Ig antibodies and swine anti-mouse Ig antibodies, respectively, were used as a second layer. The subsequent procedures used Vectastain peroxidase ABC reagents (Vector Laboratories, Burlingame, CA) for the c-myc and Ki-67 stainings and APAAP (Dakopatts, Copenhagen, Denmark) for the A-chain staining. The peroxidase activity was visualized by 3-amino-9-ethylcarbazol and the alkaline phosphatase activity by naphtol AS-MX phosphateifast blue. A minimum of 400 cells was counted.
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RESULTS

Induction of proliferative and nonproliferative differentiation of B-CLL cells. To obtain populations of cells at different levels of differentiation and proliferation, I83
B-CLL cells were induced by SAC + BSF-MP6 + TNF-a, SAC + BSF-MP6 + IL-2, TPA, and TPA + BSF-MP6 + IL-4, respectively, for 6 days. As shown in Table 1 and very high (6,480 ng/mL) in TPA + BSF-MP6 + IL-4 induced cells. This was also reflected by the percentage of plasmablasts/mature plasma cells, which was only 3% with the TNF-(r. protocol and 35% with the IL-4 protocol ( Table  1) . The DNA synthesis, as measured by 'H-TdR incorporation, was only minimal in TPA-induced cells, intermediate stimulated cells traversed the cell cycle and expressed the proliferation-associated nuclear antigen Ki-67."
c-myc mRNA expression during proliferative and nonproliferative differentiation of B-CLL cells at the population level.
To determine whether the expression of c-myc mRNA was correlated to the level of DNA synthesis, differentiation, or both, RNA purified from the different cultures was subjected to RNA gel blot analysis and hybridized to a "P-labeled c-myc probe. As shown in will represent only the average expression of c-myc mRNA at the population level. To determine whether the expression of c-myc was confined to certain subpopulations of cells, we used immunocytochemical methods to study expression of the c-myc protein at the single cell level, using an anti-human c-myc antiserum.
In contrast to the c-myc-uninduced cells, most of the stimulated cells expressed an intense nuclear staining after 4-hour TPA exposure (Fig 2A and B) . TPA-induced cells labeled with antiserum preblocked by recombinant human c-myc protein were negative, confirming the specificity of the reaction (Fig 2C) . After 6 days of TPA treatment, 90% of the cells were still c-myc+, although the intensity in staining among different cells was heterogeneous ( Table 2) (Table 1) .
Several cell populations could be defined on the basis of the combined staining of c-myc and cytoplasmic A-chain. First, regardless of the induction protocol used, approximately 5% of the cells remained myc-and A-chain-(myel-). These cells had the morphology of uninduced, small resting lymphocytes. Second, a larger group of cells were A-chain-and usually weak in c-myc staining (myc+'++A-). These cells had the morphology of small lymphocytes ( Fig 2D) Table 3 , most of the B lymphocytes among the TPA + BSF-MP6 + IL-&stimulated cells were found in these three populations. A similar distribution was observed among cells stimulated with the other inducers (data not shown).
The functionally more mature cells, defined by an intense A-chain staining, can be grouped into three populations with respect to c-myc protein expression (Table 2) . First, the fraction of those with an intense c-myc staining (myc",") was dominated by B-lymphoblasts (Table 3 , Fig  2E and F) . The frequency of these cells was elevated after induction by SAC + BSF-MP6 + IL-2, the protocol most efficiently inducing proliferation. Only a minority of the cells within this population resembled plasmablasts. Second, the fraction of weakly c-myc' cells (my+,++) mainly consisted of plasmablasts (85%) ( Table 3 , Fig 2G) and some lymphoblasts. Third, the fraction of c-myc-cells (myc-A+++) comprised small to middle-sized cells resembling plasma cells (60%) and larger plasmablasts. The c-myc-plasma cell-like cells usually exhibited a very intense A-chain staining (Fig 2H) . The c-myc+Aci and the c-myc-h"' fractions were essentially absent (3%) in cultures stimulated with the least efficient maturation-inducing protocol Table 4 .
The frequency of A-chain+ cells was increased in the PCA-l+ population. The fraction of cells with intense staining was also increased (data not shown). The most striking difference was, however, that the relative number of strongly A-chain positive c-myc-cells was increased fourfold in the PCA-l+ population.
DNA synthesis and E-67 expression at the single cell level after induced differentiation of B-CLL cells. Because TPA + BSF-MP6 + IL-4 not only induces efficient maturation of I83 cells but also a high level of DNA synthesis and an equivalent high number of Ki-67+ cells (Table l) , we wished to compare the distribution of proliferating cells among the different cell types with that of c-myc expressing cells.
Therefore, cells were induced by TPA + BSF-MP6 + IL-4 for 6 days and labeled with 'H-TdR during the last 2 or 24 hours of culture and subsequently stained for cytoplasmic A-chain or by May-Griinwald-Giemsa. In parallel, cells were double-labeled for Ki-67 and A-chain. Table 5 shows that 25% of the induced cells were Ki-67 positive and 16% The analysis was performed as described in the footnote to Table 2 .
and 33% of the cells had synthesized DNA during a 2-and 24-hour 3H-TdR pulse, respectively, as determined by autoradiography. Morphologic examination showed that most of both Ki-67' and replicating cells were B lymphoblasts. Among the total number of lymphoblasts, 65% were Ki-67 positive and 40% synthesized DNA during a 2-hour pulse as compared with only 10% to 15% among the lymphocytes and plasmablasts. No Ki-67+ or replicating cells with plasma cell morphology were observed; however, 46% of the plasmablasts and 13% of the plasma cells had synthesized DNA during the last 24 hours of a 6-day stimulation.
DISCUSSION
Our previous studies showed that TPA-induced nonproliferative differentiation of B-CLL cells was associated with a drastically increased c-myc expression,m which contrasted with the reduced c-myc expression observed during in vitro differentiation of several myeloid and erythroid cell lines. Our results thus suggest that expression of c-myc protein is downregulated at the most terminal stages of B-CLL differentiation. This suggestion is based on the following observations. First, the c-myc-and strongly A-chain+ (myc-A+++) cells resemble plasma cells and plasmablasts by the shape and size, the low nuclearkytoplasmic ratio, and the relatively small nucleus, positioned eccentrically in the prominent cytoplasm. Cytoplasmic and nuclear structures, eg, the Golgi complex, nucleoli and the chromatin are difficult to evaluate by this technique, however. Second, myc-A+++ are the most intensely anti-A-chain-stained cells observed. Third, the fraction of the myc-A+++ cells correlates in size with the efficiency of the induction protocols to The cells were labeled with 1 pCi 3H TdR for the last 2 or 24 hours of the 6-day culture and were fixed and subjected to autoradiography as described in the Materials and Methods section. Based on the present results, which are summarized in Fig 3, we suggest that the differentiation process is separable into two stages. The first stage is associated with an induced c-myc expression and is characterized by transition of the cells from Go to G,, acquisition of responsiveness to growtwdifferentiation factors, blast transformation, transition through the cell cycle and initiation of Ig production. The second stage, during which c-myc expression is downregulated, begins during the plasma blast stage and is characterized by a high level of Ig production and secretion, condensation of the chromatin, and exit from the cell cycle.
The increased relative frequency of plasmablasts and plasma cells that had incorporated 'H-TdR during the last 24 hours as compared with a 2-hour pulse after 6-day stimulation with TPA + BSF-MP6 + I L 4 (Table 5) indicates a flow of cells through the cycling lymphoblast compartment into the mature noncycling plasmablast/ plasma cell compartment, as shown in Fig 4. The results also show that differentiation with concomitant proliferation is far more efficient in producing mature plasma cells For personal use only. on October 3, 2017. by guest www.bloodjournal.org From
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than is the nonproliferative TPA protocol. Anderson and M e l c h e r~~~ suggested that proliferation is even necessary to obtain terminally differentiated plasma cells. The IL-4 protocol thus induces both growth and an efficient differentiation. The IL-2 protocol, on the other hand, appears to maintain the cells within the cell cycle to a greater extent and thus favors self-renewal at the expense of maturation (Fig 4) . The high level of c-myc expression induced by IL-2 may affect the balance between self-renewal and differentiation in these cells. Such observations have been made in transgenic mice expressing a EpJmyc gene that results in an accumulation of proliferating immature B cells. 37 The present results are thus in agreement with the observations in MEL,I3 HL-60,I4 and U-937153'6 that c-myc expression is downregulated during the terminal part of differentiation, associated with growth arrest. The results also suggest that the translocated c-myc gene in BL and MPC is expressed at a stage of differentiation, corresponding roughly to the resting B cell and plasmablast stage, respectively, during which c-myc expression in B-CLL is downregulated. Kakkis and Calame" suggested that the transcriptional repression of the normal c-myc allele observed in MPC is mediated by a regulatory DNA-binding protein that is specifically active in plasmacytomas but not in B cells at an earlier stage of differentiation. One may hypothesize that the deregulated c-myc expression in BL and MPC cells, similarly to the situation in c-or v-myc expressing MEL," U-937 cells,'6 avian macrophages," and murine preadipocytes,* make them unable to enter a resting state (GdG,) and to complete the differentiation process.
